Preimplantation Genetic Diagnosis (PGD) by Array Comparative Genome Hybridization (CGH) and Blastocyst Biopsy

PHASE3TerminatedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

September 30, 2012

Conditions
InfertilityMiscarriage
Interventions
GENETIC

Preimplantation Genetic Diagnosis

All embryos in the test group reaching blastocyst stage will undergo embryo biopsy of 3-10 trophectoderm cells. The cells will be analyzed by array CGH to detect the presence or not of chromosome abnormalities. The embryos will be vitrified and those classified by array CGH as normal, thawed for replacement.

Trial Locations (1)

Unknown

Pranor, Lima

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Reprogenetics Lationoamerica S.A.C, Lima, Peru

UNKNOWN

collaborator

Pranor S.R.L., Lima, Peru

UNKNOWN

collaborator

Yale University

OTHER

collaborator

McGill University

OTHER

lead

Reprogenetics

INDUSTRY

NCT01332643 - Preimplantation Genetic Diagnosis (PGD) by Array Comparative Genome Hybridization (CGH) and Blastocyst Biopsy | Biotech Hunter | Biotech Hunter